Caterpillar Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Two decreased by 16.7% to $5.00M in Q4 2025 compared to the prior quarter. Over 2 years (FY 2023 to FY 2025), Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Two shows a downward trend with a -8.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Consistent or increasing receipts suggest stable long-term support for retiree benefit costs.
This represents the expected cash inflows from government subsidies related to prescription drug benefits provided under...
Standard disclosure for companies with significant legacy retiree healthcare liabilities.
other_prescription_drug_subsidy_receipts_year_two1| Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|
| Value | $6.00M | $6.00M | $5.00M |
| QoQ Change | — | +0.0% | -16.7% |
| YoY Change | — | +0.0% | -16.7% |